(Q36822317)

16 August 2017

1 reference

title

Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy (English)

1 reference

16 August 2017

0 references

1 reference

1 reference

Brinda S Desai

1

1 reference

16 August 2017

Angela J Monahan

series ordinal

2

1 reference

16 August 2017

Paul M Carvey

series ordinal

3

1 reference

16 August 2017

Bill Hendey

series ordinal

4

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

16

1 reference

16 August 2017

285-299

1 reference

16 August 2017

3

1 reference

Astrocyte-endothelial interactions and blood-brain barrier permeability

16 August 2017

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Alterations of T-lymphocyte populations in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Blood-brain barrier transport of cytokines: a mechanism for neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

The dam breaks: disruption of the blood-brain barrier in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Efflux of human and mouse amyloid β proteins 1–40 and 1–42 from brain: impairment in a mouse model of alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Blood vessels and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Parkinson's disease and inflammatory changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Neural induction of the blood-brain barrier: still an enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Clinical potential of minocycline for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

MPP(+) injection into rat substantia nigra causes secondary glial activation but not cell death in the ipsilateral striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Cerebral microvascular pathology in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Genomewide association, Parkinson disease, and PARK10

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Structural and Functional Variations in Capillary Systems within the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Neuroinflammatory processes in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Tight junctions of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

The etiology of Parkinson's disease with emphasis on the MPTP story

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Cell therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Microvascular dysfunction in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

GLUT-1 expression in the cerebra of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

The large apparent work capability of the blood-brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Glial cell influence on the human blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Changes in blood-brain barrier permeability following neurotoxic lesions of rat brain can be visualised with trypan blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Levodopa with benserazide or carbidopa in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Clinical aspects of inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

The cell biology of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Alzheimer disease and its management: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Microglia and Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Microglia and neuroinflammation: a pathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Mechanisms of the blood-brain barrier disruption in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

T-cells in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Phagocytosis of ?/A4 amyloid fibrils of the neuritic neocortical plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

Neurovascular pathways and Alzheimer amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000007783464731

10.3727/000000007783464731

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference